APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Vaccines

Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.

Selected research

Market Analysis & Forecast

Global Oral Vaccines Market Analysis and Forecast 2026-2032

2 January 2026191 pages

Choose your research edition.

Industry ResearchOral Vaccines Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Vaccines Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Oral Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Vaccines Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Vaccines Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.

The classification of oral vaccines includes rotavirus vaccine, cholera vaccine, oral polio vaccine and other types, and the sales proportion of polio vaccine is about 94%.

Middle East and Africa is the largest consumption place, with a consumption market share nearly 54%. Following Middle East and Africa, Asia-Pacific is the second largest consumption place with the consumption market share of 31%.

Read the full market overview

Market competition is intense. Merck, GSK and Sanofi, etc. are the leaders of the industry, with about 78% market shares.

This report presents an overview of global market for Oral Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Oral Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Oral Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Oral Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Oral Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Oral Vaccines sales, projected growth trends, production technology, application and end-user industry.

Oral Vaccines Segment by Company

Merck

GSK

Sanofi

Lanzhou Institute

Serum Institute

Valneva

Shanghai United Cell

Bibcol

PaxVax

Vabiotech

Tiantan Biological

EuBiologics

Panacea Biotec Ltd

Bio-Med

Halfkin Bio-Pharmaceuticals

Oral Vaccines Segment by Type

Rotavirus Vaccine

Cholera Vaccine

Oral Polio Vaccine

Oral Vaccines Segment by Application

Public

Private

Oral Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Oral Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Oral Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oral Vaccines sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Oral Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Rotavirus Vaccine Major Manufacturers Table 3. Cholera Vaccine Major Manufacturers Table 4. Oral Polio Vaccine Major Manufacturers Table 5. Global Oral Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Public Major Manufacturers Table 7. Private Major Manufacturers Table 8. Oral Vaccines Industry Trends Table 9. Oral Vaccines Industry Drivers Table 10. Oral Vaccines Industry Opportunities and Challenges Table 11. Oral Vaccines Industry Restraints Table 12. Global Oral Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Oral Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Oral Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Oral Vaccines Revenue Market Share by Region (2021-2026) Table 16. Global Oral Vaccines Revenue Market Share by Region (2027-2032) Table 17. Global Oral Vaccines Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M Doses) Table 18. Global Oral Vaccines Sales by Region (2021-2026) & (M Doses) Table 19. Global Oral Vaccines Sales by Region (2027-2032) & (M Doses) Table 20. Global Oral Vaccines Sales Market Share by Region (2021-2026) Table 21. Global Oral Vaccines Sales Market Share by Region (2027-2032) Table 22. Global Oral Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Oral Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Oral Vaccines Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Oral Vaccines Sales Market Share by Manufacturers (2021-2026) Table 26. Global Oral Vaccines Sales Price (USD/K Doses) of Manufacturers (2021-2026) Table 27. Global Oral Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Oral Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Oral Vaccines Manufacturers, Product Type & Application Table 30. Global Oral Vaccines Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Oral Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Oral Vaccines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Oral Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Oral Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Oral Vaccines Revenue Market Share by Type (2021-2026) Table 37. Global Oral Vaccines Revenue Market Share by Type (2027-2032) Table 38. Global Oral Vaccines Sales by Type 2021 VS 2025 VS 2032 (M Doses) Table 39. Global Oral Vaccines Sales by Type (2021-2026) & (M Doses) Table 40. Global Oral Vaccines Sales by Type (2027-2032) & (M Doses) Table 41. Global Oral Vaccines Sales Market Share by Type (2021-2026) Table 42. Global Oral Vaccines Sales Market Share by Type (2027-2032) Table 43. Global Oral Vaccines Price by Type (2021-2026) & (USD/K Doses) Table 44. Global Oral Vaccines Price by Type (2027-2032) & (USD/K Doses) Table 45. Global Oral Vaccines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Oral Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Oral Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Oral Vaccines Revenue Market Share by Application (2021-2026) Table 49. Global Oral Vaccines Revenue Market Share by Application (2027-2032) Table 50. Global Oral Vaccines Sales by Application 2021 VS 2025 VS 2032 (M Doses) Table 51. Global Oral Vaccines Sales by Application (2021-2026) & (M Doses) Table 52. Global Oral Vaccines Sales by Application (2027-2032) & (M Doses) Table 53. Global Oral Vaccines Sales Market Share by Application (2021-2026) Table 54. Global Oral Vaccines Sales Market Share by Application (2027-2032) Table 55. Global Oral Vaccines Price by Application (2021-2026) & (USD/K Doses) Table 56. Global Oral Vaccines Price by Application (2027-2032) & (USD/K Doses) Table 57. Merck Company Information Table 58. Merck Business Overview Table 59. Merck Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 60. Merck Oral Vaccines Product Portfolio Table 61. Merck Recent Development Table 62. GSK Company Information Table 63. GSK Business Overview Table 64. GSK Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 65. GSK Oral Vaccines Product Portfolio Table 66. GSK Recent Development Table 67. Sanofi Company Information Table 68. Sanofi Business Overview Table 69. Sanofi Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 70. Sanofi Oral Vaccines Product Portfolio Table 71. Sanofi Recent Development Table 72. Lanzhou Institute Company Information Table 73. Lanzhou Institute Business Overview Table 74. Lanzhou Institute Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 75. Lanzhou Institute Oral Vaccines Product Portfolio Table 76. Lanzhou Institute Recent Development Table 77. Serum Institute Company Information Table 78. Serum Institute Business Overview Table 79. Serum Institute Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 80. Serum Institute Oral Vaccines Product Portfolio Table 81. Serum Institute Recent Development Table 82. Valneva Company Information Table 83. Valneva Business Overview Table 84. Valneva Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 85. Valneva Oral Vaccines Product Portfolio Table 86. Valneva Recent Development Table 87. Shanghai United Cell Company Information Table 88. Shanghai United Cell Business Overview Table 89. Shanghai United Cell Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 90. Shanghai United Cell Oral Vaccines Product Portfolio Table 91. Shanghai United Cell Recent Development Table 92. Bibcol Company Information Table 93. Bibcol Business Overview Table 94. Bibcol Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 95. Bibcol Oral Vaccines Product Portfolio Table 96. Bibcol Recent Development Table 97. PaxVax Company Information Table 98. PaxVax Business Overview Table 99. PaxVax Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 100. PaxVax Oral Vaccines Product Portfolio Table 101. PaxVax Recent Development Table 102. Vabiotech Company Information Table 103. Vabiotech Business Overview Table 104. Vabiotech Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 105. Vabiotech Oral Vaccines Product Portfolio Table 106. Vabiotech Recent Development Table 107. Tiantan Biological Company Information Table 108. Tiantan Biological Business Overview Table 109. Tiantan Biological Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 110. Tiantan Biological Oral Vaccines Product Portfolio Table 111. Tiantan Biological Recent Development Table 112. EuBiologics Company Information Table 113. EuBiologics Business Overview Table 114. EuBiologics Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 115. EuBiologics Oral Vaccines Product Portfolio Table 116. EuBiologics Recent Development Table 117. Panacea Biotec Ltd Company Information Table 118. Panacea Biotec Ltd Business Overview Table 119. Panacea Biotec Ltd Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 120. Panacea Biotec Ltd Oral Vaccines Product Portfolio Table 121. Panacea Biotec Ltd Recent Development Table 122. Bio-Med Company Information Table 123. Bio-Med Business Overview Table 124. Bio-Med Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 125. Bio-Med Oral Vaccines Product Portfolio Table 126. Bio-Med Recent Development Table 127. Halfkin Bio-Pharmaceuticals Company Information Table 128. Halfkin Bio-Pharmaceuticals Business Overview Table 129. Halfkin Bio-Pharmaceuticals Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 130. Halfkin Bio-Pharmaceuticals Oral Vaccines Product Portfolio Table 131. Halfkin Bio-Pharmaceuticals Recent Development Table 132. North America Oral Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 133. North America Oral Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 134. North America Oral Vaccines Sales by Type (2021-2026) & (M Doses) Table 135. North America Oral Vaccines Sales by Type (2027-2032) & (M Doses) Table 136. North America Oral Vaccines Sales Price by Type (2021-2026) & (USD/K Doses) Table 137. North America Oral Vaccines Sales Price by Type (2027-2032) & (USD/K Doses) Table 138. North America Oral Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 139. North America Oral Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 140. North America Oral Vaccines Sales by Application (2021-2026) & (M Doses) Table 141. North America Oral Vaccines Sales by Application (2027-2032) & (M Doses) Table 142. North America Oral Vaccines Sales Price by Application (2021-2026) & (USD/K Doses) Table 143. North America Oral Vaccines Sales Price by Application (2027-2032) & (USD/K Doses) Table 144. North America Oral Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. North America Oral Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 146. North America Oral Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 147. North America Oral Vaccines Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 148. North America Oral Vaccines Sales by Country (2021-2026) & (M Doses) Table 149. North America Oral Vaccines Sales by Country (2027-2032) & (M Doses) Table 150. North America Oral Vaccines Sales Price by Country (2021-2026) & (USD/K Doses) Table 151. North America Oral Vaccines Sales Price by Country (2027-2032) & (USD/K Doses) Table 152. United States Oral Vaccines Revenue (2021-2032) & (US$ Million) Table 153. Canada Oral Vaccines Revenue (2021-2032) & (US$ Million) Table 154. Mexico Oral Vaccines Revenue (2021-2032) & (US$ Million) Table 155. Europe Oral Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 156. Europe Oral Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 157. Europe Oral Vaccines Sales by Type (2021-2026) & (M Doses) Table 158. Europe Oral Vaccines Sales by Type (2027-2032) & (M Doses) Table 159. Europe Oral Vaccines Sales Price by Type (2021-2026) & (USD/K Doses) Table 160. Europe Oral Vaccines Sales Price by Type (2027-2032) & (USD/K Doses) Table 161. Europe Oral Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 162. Europe Oral Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 163. Europe Oral Vaccines Sales by Application (2021-2026) & (M Doses) Table 164. Europe Oral Vaccines Sales by Application (2027-2032) & (M Doses) Table 165. Europe Oral Vaccines Sales Price by Application (2021-2026) & (USD/K Doses) Table 166. Europe Oral Vaccines Sales Price by Application (2027-2032) & (USD/K Doses) Table 167. Europe Oral Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 168. Europe Oral Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 169. Europe Oral Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 170. Europe Oral Vaccines Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 171. Europe Oral Vaccines Sales by Country (2021-2026) & (M Doses) Table 172. Europe Oral Vaccines Sales by Country (2027-2032) & (M Doses) Table 173. Europe Oral Vaccines Sales Price by Country (2021-2026) & (USD/K Doses) Table 174. Europe Oral Vaccines Sales Price by Country (2027-2032) & (USD/K Doses) Table 175. Germany Oral Vaccines Revenue (2021-2032) & (US$ Million) Table 176. France Oral Vaccines Revenue (2021-2032) & (US$ Million) Table 177. U.K. Oral Vaccines Revenue (2021-2032) & (US$ Million) Table 178. Italy Oral Vaccines Revenue (2021-2032) & (US$ Million) Table 179. Russia Oral Vaccines Revenue (2021-2032) & (US$ Million) Table 180. Spain Oral Vaccines Revenue (2021-2032) & (US$ Million) Table 181. Netherlands Oral Vaccines Revenue (2021-2032) & (US$ Million) Table 182. Switzerland Oral Vaccines Revenue (2021-2032) & (US$ Million) Table 183. Sweden Oral Vaccines Revenue (2021-2032) & (US$ Million) Table 184. Poland Oral Vaccines Revenue (2021-2032) & (US$ Million) Table 185. China Oral Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 186. China Oral Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 187. China Oral Vaccines Sales by Type (2021-2026) & (M Doses) Table 188. China Oral Vaccines Sales by Type (2027-2032) & (M Doses) Table 189. China Oral Vaccines Sales Price by Type (2021-2026) & (USD/K Doses) Table 190. China Oral Vaccines Sales Price by Type (2027-2032) & (USD/K Doses) Table 191. China Oral Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 192. China Oral Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 193. China Oral Vaccines Sales by Application (2021-2026) & (M Doses) Table 194. China Oral Vaccines Sales by Application (2027-2032) & (M Doses) Table 195. China Oral Vaccines Sales Price by Application (2021-2026) & (USD/K Doses) Table 196. China Oral Vaccines Sales Price by Application (2027-2032) & (USD/K Doses) Table 197. Asia Oral Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 198. Asia Oral Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 199. Asia Oral Vaccines Sales by Type (2021-2026) & (M Doses) Table 200. Asia Oral Vaccines Sales by Type (2027-2032) & (M Doses) Table 201. Asia Oral Vaccines Sales Price by Type (2021-2026) & (USD/K Doses) Table 202. Asia Oral Vaccines Sales Price by Type (2027-2032) & (USD/K Doses) Table 203. Asia Oral Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 204. Asia Oral Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 205. Asia Oral Vaccines Sales by Application (2021-2026) & (M Doses) Table 206. Asia Oral Vaccines Sales by Application (2027-2032) & (M Doses) Table 207. Asia Oral Vaccines Sales Price by Application (2021-2026) & (USD/K Doses) Table 208. Asia Oral Vaccines Sales Price by Application (2027-2032) & (USD/K Doses) Table 209. Asia Oral Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 210. Asia Oral Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 211. Asia Oral Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 212. Asia Oral Vaccines Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 213. Asia Oral Vaccines Sales by Country (2021-2026) & (M Doses) Table 214. Asia Oral Vaccines Sales by Country (2027-2032) & (M Doses) Table 215. Asia Oral Vaccines Sales Price by Country (2021-2026) & (USD/K Doses) Table 216. Asia Oral Vaccines Sales Price by Country (2027-2032) & (USD/K Doses) Table 217. Japan Oral Vaccines Revenue (2021-2032) & (US$ Million) Table 218. South Korea Oral Vaccines Revenue (2021-2032) & (US$ Million) Table 219. India Oral Vaccines Revenue (2021-2032) & (US$ Million) Table 220. Australia Oral Vaccines Revenue (2021-2032) & (US$ Million) Table 221. Taiwan Oral Vaccines Revenue (2021-2032) & (US$ Million) Table 222. Southeast Asia Oral Vaccines Revenue (2021-2032) & (US$ Million) Table 223. SAMEA Oral Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 224. SAMEA Oral Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 225. SAMEA Oral Vaccines Sales by Type (2021-2026) & (M Doses) Table 226. SAMEA Oral Vaccines Sales by Type (2027-2032) & (M Doses) Table 227. SAMEA Oral Vaccines Sales Price by Type (2021-2026) & (USD/K Doses) Table 228. SAMEA Oral Vaccines Sales Price by Type (2027-2032) & (USD/K Doses) Table 229. SAMEA Oral Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 230. SAMEA Oral Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 231. SAMEA Oral Vaccines Sales by Application (2021-2026) & (M Doses) Table 232. SAMEA Oral Vaccines Sales by Application (2027-2032) & (M Doses) Table 233. SAMEA Oral Vaccines Sales Price by Application (2021-2026) & (USD/K Doses) Table 234. SAMEA Oral Vaccines Sales Price by Application (2027-2032) & (USD/K Doses) Table 235. SAMEA Oral Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 236. SAMEA Oral Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 237. SAMEA Oral Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 238. SAMEA Oral Vaccines Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 239. SAMEA Oral Vaccines Sales by Country (2021-2026) & (M Doses) Table 240. SAMEA Oral Vaccines Sales by Country (2027-2032) & (M Doses) Table 241. SAMEA Oral Vaccines Sales Price by Country (2021-2026) & (USD/K Doses) Table 242. SAMEA Oral Vaccines Sales Price by Country (2027-2032) & (USD/K Doses) Table 243. Brazil Oral Vaccines Revenue (2021-2032) & (US$ Million) Table 244. Argentina Oral Vaccines Revenue (2021-2032) & (US$ Million) Table 245. Chile Oral Vaccines Revenue (2021-2032) & (US$ Million) Table 246. Colombia Oral Vaccines Revenue (2021-2032) & (US$ Million) Table 247. Peru Oral Vaccines Revenue (2021-2032) & (US$ Million) Table 248. Saudi Arabia Oral Vaccines Revenue (2021-2032) & (US$ Million) Table 249. Israel Oral Vaccines Revenue (2021-2032) & (US$ Million) Table 250. UAE Oral Vaccines Revenue (2021-2032) & (US$ Million) Table 251. Turkey Oral Vaccines Revenue (2021-2032) & (US$ Million) Table 252. Iran Oral Vaccines Revenue (2021-2032) & (US$ Million) Table 253. Egypt Oral Vaccines Revenue (2021-2032) & (US$ Million) Table 254. Key Raw Materials Table 255. Raw Materials Key Suppliers Table 256. Oral Vaccines Distributors List Table 257. Oral Vaccines Customers List Table 258. Research Programs/Design for This Report Table 259. Authors List of This Report Table 260. Secondary Sources Table 261. Primary Sources List of Figures Figure 1. Oral Vaccines Image Figure 2. Global Oral Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 4. Rotavirus Vaccine Image Figure 5. Cholera Vaccine Image Figure 6. Oral Polio Vaccine Image Figure 7. Global Oral Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Oral Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 9. Public Image Figure 10. Private Image Figure 11. Global Oral Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Oral Vaccines Revenue (2021-2032) & (US$ Million) Figure 13. Global Oral Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Oral Vaccines Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Oral Vaccines Revenue Market Share by Region (2021-2032) Figure 16. Global Oral Vaccines Sales (2021-2032) & (M Doses) Figure 17. Global Oral Vaccines Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Figure 18. Global Oral Vaccines Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Oral Vaccines Sales YoY (2021-2032) & (M Doses) Figure 20. Europe Oral Vaccines Sales YoY (2021-2032) & (M Doses) Figure 21. China Oral Vaccines Sales YoY (2021-2032) & (M Doses) Figure 22. Asia (Excluding China) Oral Vaccines Sales YoY (2021-2032) & (M Doses) Figure 23. South America, Middle East and Africa Oral Vaccines Sales YoY (2021-2032) & (M Doses) Figure 24. Global Oral Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Oral Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Oral Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Oral Vaccines Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Oral Vaccines Revenue Market Share by Type (2021-2032) Figure 30. Global Oral Vaccines Sales by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 31. Global Oral Vaccines Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Oral Vaccines Sales Market Share by Type (2021-2032) Figure 33. Global Oral Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Oral Vaccines Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Oral Vaccines Revenue Market Share by Application (2021-2032) Figure 36. Global Oral Vaccines Sales by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 37. Global Oral Vaccines Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Oral Vaccines Sales Market Share by Application (2021-2032) Figure 39. North America Oral Vaccines Revenue Share by Type (2021-2032) Figure 40. North America Oral Vaccines Sales Share by Type (2021-2032) Figure 41. North America Oral Vaccines Revenue Share by Application (2021-2032) Figure 42. North America Oral Vaccines Sales Share by Application (2021-2032) Figure 43. North America Oral Vaccines Revenue Share by Country (2021-2032) Figure 44. North America Oral Vaccines Sales Share by Country (2021-2032) Figure 45. Europe Oral Vaccines Revenue Share by Type (2021-2032) Figure 46. Europe Oral Vaccines Sales Share by Type (2021-2032) Figure 47. Europe Oral Vaccines Revenue Share by Application (2021-2032) Figure 48. Europe Oral Vaccines Sales Share by Application (2021-2032) Figure 49. Europe Oral Vaccines Revenue Share by Country (2021-2032) Figure 50. Europe Oral Vaccines Sales Share by Country (2021-2032) Figure 51. China Oral Vaccines Revenue Share by Type (2021-2032) Figure 52. China Oral Vaccines Sales Share by Type (2021-2032) Figure 53. China Oral Vaccines Revenue Share by Application (2021-2032) Figure 54. China Oral Vaccines Sales Share by Application (2021-2032) Figure 55. Asia Oral Vaccines Revenue Share by Type (2021-2032) Figure 56. Asia Oral Vaccines Sales Share by Type (2021-2032) Figure 57. Asia Oral Vaccines Revenue Share by Application (2021-2032) Figure 58. Asia Oral Vaccines Sales Share by Application (2021-2032) Figure 59. Asia Oral Vaccines Revenue Share by Country (2021-2032) Figure 60. Asia Oral Vaccines Sales Share by Country (2021-2032) Figure 61. SAMEA Oral Vaccines Revenue Share by Type (2021-2032) Figure 62. SAMEA Oral Vaccines Sales Share by Type (2021-2032) Figure 63. SAMEA Oral Vaccines Revenue Share by Application (2021-2032) Figure 64. SAMEA Oral Vaccines Sales Share by Application (2021-2032) Figure 65. SAMEA Oral Vaccines Revenue Share by Country (2021-2032) Figure 66. SAMEA Oral Vaccines Sales Share by Country (2021-2032) Figure 67. Oral Vaccines Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Oral Vaccines Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Rotavirus Vaccine
  • Cholera Vaccine
  • Oral Polio Vaccine
Applications
  • Public
  • Private
Companies covered
  • Merck
  • GSK
  • Sanofi
  • Lanzhou Institute
  • Serum Institute
  • Valneva
  • Shanghai United Cell
  • Bibcol
  • PaxVax
  • Vabiotech
  • Tiantan Biological
  • EuBiologics
  • Panacea Biotec Ltd
  • Bio-Med
  • Halfkin Bio-Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Oral Vaccines Market by Type
  3. 1.2.1 Global Oral Vaccines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Rotavirus Vaccine
  5. 1.2.3 Cholera Vaccine
  6. 1.2.4 Oral Polio Vaccine
  7. 1.3 Oral Vaccines Market by Application
  8. 1.3.1 Global Oral Vaccines Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Public
  10. 1.3.3 Private
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Oral Vaccines Market Dynamics
  1. 2.1 Oral Vaccines Industry Trends
  2. 2.2 Oral Vaccines Industry Drivers
  3. 2.3 Oral Vaccines Industry Opportunities and Challenges
  4. 2.4 Oral Vaccines Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Oral Vaccines Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Oral Vaccines Revenue by Region
  3. 3.2.1 Global Oral Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Oral Vaccines Revenue by Region (2021-2026)
  5. 3.2.3 Global Oral Vaccines Revenue by Region (2027-2032)
  6. 3.2.4 Global Oral Vaccines Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Oral Vaccines Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Oral Vaccines Sales by Region
  9. 3.4.1 Global Oral Vaccines Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Oral Vaccines Sales by Region (2021-2026)
  11. 3.4.3 Global Oral Vaccines Sales by Region (2027-2032)
  12. 3.4.4 Global Oral Vaccines Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Oral Vaccines Revenue by Manufacturers
  2. 4.1.1 Global Oral Vaccines Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Oral Vaccines Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Oral Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Oral Vaccines Sales by Manufacturers
  6. 4.2.1 Global Oral Vaccines Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Oral Vaccines Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Oral Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Oral Vaccines Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Oral Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Oral Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Oral Vaccines Manufacturers, Product Type & Application
  13. 4.7 Global Oral Vaccines Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Oral Vaccines Market CR5 and HHI
  16. 4.8.2 2025 Oral Vaccines Tier 1, Tier 2, and Tier 3
5 Oral Vaccines Market by Type
  1. 5.1 Global Oral Vaccines Revenue by Type
  2. 5.1.1 Global Oral Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Oral Vaccines Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Oral Vaccines Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Oral Vaccines Sales by Type
  6. 5.2.1 Global Oral Vaccines Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Oral Vaccines Sales by Type (2021-2032) & (M Doses)
  8. 5.2.3 Global Oral Vaccines Sales Market Share by Type (2021-2032)
  9. 5.3 Global Oral Vaccines Price by Type
6 Oral Vaccines Market by Application
  1. 6.1 Global Oral Vaccines Revenue by Application
  2. 6.1.1 Global Oral Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Oral Vaccines Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Oral Vaccines Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Oral Vaccines Sales by Application
  6. 6.2.1 Global Oral Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Oral Vaccines Sales by Application (2021-2032) & (M Doses)
  8. 6.2.3 Global Oral Vaccines Sales Market Share by Application (2021-2032)
  9. 6.3 Global Oral Vaccines Price by Application
7 Company Profiles
  1. 7.1 Merck
  2. 7.1.1 Merck Company Information
  3. 7.1.2 Merck Business Overview
  4. 7.1.3 Merck Oral Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Merck Oral Vaccines Product Portfolio
  6. 7.1.5 Merck Recent Developments
  7. 7.2 GSK
  8. 7.2.1 GSK Company Information
  9. 7.2.2 GSK Business Overview
  10. 7.2.3 GSK Oral Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 GSK Oral Vaccines Product Portfolio
  12. 7.2.5 GSK Recent Developments
  13. 7.3 Sanofi
  14. 7.3.1 Sanofi Company Information
  15. 7.3.2 Sanofi Business Overview
  16. 7.3.3 Sanofi Oral Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sanofi Oral Vaccines Product Portfolio
  18. 7.3.5 Sanofi Recent Developments
  19. 7.4 Lanzhou Institute
  20. 7.4.1 Lanzhou Institute Company Information
  21. 7.4.2 Lanzhou Institute Business Overview
  22. 7.4.3 Lanzhou Institute Oral Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Lanzhou Institute Oral Vaccines Product Portfolio
  24. 7.4.5 Lanzhou Institute Recent Developments
  25. 7.5 Serum Institute
  26. 7.5.1 Serum Institute Company Information
  27. 7.5.2 Serum Institute Business Overview
  28. 7.5.3 Serum Institute Oral Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Serum Institute Oral Vaccines Product Portfolio
  30. 7.5.5 Serum Institute Recent Developments
  31. 7.6 Valneva
  32. 7.6.1 Valneva Company Information
  33. 7.6.2 Valneva Business Overview
  34. 7.6.3 Valneva Oral Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Valneva Oral Vaccines Product Portfolio
  36. 7.6.5 Valneva Recent Developments
  37. 7.7 Shanghai United Cell
  38. 7.7.1 Shanghai United Cell Company Information
  39. 7.7.2 Shanghai United Cell Business Overview
  40. 7.7.3 Shanghai United Cell Oral Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Shanghai United Cell Oral Vaccines Product Portfolio
  42. 7.7.5 Shanghai United Cell Recent Developments
  43. 7.8 Bibcol
  44. 7.8.1 Bibcol Company Information
  45. 7.8.2 Bibcol Business Overview
  46. 7.8.3 Bibcol Oral Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Bibcol Oral Vaccines Product Portfolio
  48. 7.8.5 Bibcol Recent Developments
  49. 7.9 PaxVax
  50. 7.9.1 PaxVax Company Information
  51. 7.9.2 PaxVax Business Overview
  52. 7.9.3 PaxVax Oral Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 PaxVax Oral Vaccines Product Portfolio
  54. 7.9.5 PaxVax Recent Developments
  55. 7.10 Vabiotech
  56. 7.10.1 Vabiotech Company Information
  57. 7.10.2 Vabiotech Business Overview
  58. 7.10.3 Vabiotech Oral Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Vabiotech Oral Vaccines Product Portfolio
  60. 7.10.5 Vabiotech Recent Developments
  61. 7.11 Tiantan Biological
  62. 7.11.1 Tiantan Biological Company Information
  63. 7.11.2 Tiantan Biological Business Overview
  64. 7.11.3 Tiantan Biological Oral Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Tiantan Biological Oral Vaccines Product Portfolio
  66. 7.11.5 Tiantan Biological Recent Developments
  67. 7.12 EuBiologics
  68. 7.12.1 EuBiologics Company Information
  69. 7.12.2 EuBiologics Business Overview
  70. 7.12.3 EuBiologics Oral Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 EuBiologics Oral Vaccines Product Portfolio
  72. 7.12.5 EuBiologics Recent Developments
  73. 7.13 Panacea Biotec Ltd
  74. 7.13.1 Panacea Biotec Ltd Company Information
  75. 7.13.2 Panacea Biotec Ltd Business Overview
  76. 7.13.3 Panacea Biotec Ltd Oral Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Panacea Biotec Ltd Oral Vaccines Product Portfolio
  78. 7.13.5 Panacea Biotec Ltd Recent Developments
  79. 7.14 Bio-Med
  80. 7.14.1 Bio-Med Company Information
  81. 7.14.2 Bio-Med Business Overview
  82. 7.14.3 Bio-Med Oral Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Bio-Med Oral Vaccines Product Portfolio
  84. 7.14.5 Bio-Med Recent Developments
  85. 7.15 Halfkin Bio-Pharmaceuticals
  86. 7.15.1 Halfkin Bio-Pharmaceuticals Company Information
  87. 7.15.2 Halfkin Bio-Pharmaceuticals Business Overview
  88. 7.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Halfkin Bio-Pharmaceuticals Oral Vaccines Product Portfolio
  90. 7.15.5 Halfkin Bio-Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Oral Vaccines Market Size by Type
  2. 8.1.1 North America Oral Vaccines Revenue by Type (2021-2032)
  3. 8.1.2 North America Oral Vaccines Sales by Type (2021-2032)
  4. 8.1.3 North America Oral Vaccines Price by Type (2021-2032)
  5. 8.2 North America Oral Vaccines Market Size by Application
  6. 8.2.1 North America Oral Vaccines Revenue by Application (2021-2032)
  7. 8.2.2 North America Oral Vaccines Sales by Application (2021-2032)
  8. 8.2.3 North America Oral Vaccines Price by Application (2021-2032)
  9. 8.3 North America Oral Vaccines Market Size by Country
  10. 8.3.1 North America Oral Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Oral Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Oral Vaccines Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Oral Vaccines Market Size by Type
  2. 9.1.1 Europe Oral Vaccines Revenue by Type (2021-2032)
  3. 9.1.2 Europe Oral Vaccines Sales by Type (2021-2032)
  4. 9.1.3 Europe Oral Vaccines Price by Type (2021-2032)
  5. 9.2 Europe Oral Vaccines Market Size by Application
  6. 9.2.1 Europe Oral Vaccines Revenue by Application (2021-2032)
  7. 9.2.2 Europe Oral Vaccines Sales by Application (2021-2032)
  8. 9.2.3 Europe Oral Vaccines Price by Application (2021-2032)
  9. 9.3 Europe Oral Vaccines Market Size by Country
  10. 9.3.1 Europe Oral Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Oral Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Oral Vaccines Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Oral Vaccines Market Size by Type
  2. 10.1.1 China Oral Vaccines Revenue by Type (2021-2032)
  3. 10.1.2 China Oral Vaccines Sales by Type (2021-2032)
  4. 10.1.3 China Oral Vaccines Price by Type (2021-2032)
  5. 10.2 China Oral Vaccines Market Size by Application
  6. 10.2.1 China Oral Vaccines Revenue by Application (2021-2032)
  7. 10.2.2 China Oral Vaccines Sales by Application (2021-2032)
  8. 10.2.3 China Oral Vaccines Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Oral Vaccines Market Size by Type
  2. 11.1.1 Asia Oral Vaccines Revenue by Type (2021-2032)
  3. 11.1.2 Asia Oral Vaccines Sales by Type (2021-2032)
  4. 11.1.3 Asia Oral Vaccines Price by Type (2021-2032)
  5. 11.2 Asia Oral Vaccines Market Size by Application
  6. 11.2.1 Asia Oral Vaccines Revenue by Application (2021-2032)
  7. 11.2.2 Asia Oral Vaccines Sales by Application (2021-2032)
  8. 11.2.3 Asia Oral Vaccines Price by Application (2021-2032)
  9. 11.3 Asia Oral Vaccines Market Size by Country
  10. 11.3.1 Asia Oral Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Oral Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Oral Vaccines Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Oral Vaccines Market Size by Type
  2. 12.1.1 SAMEA Oral Vaccines Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Oral Vaccines Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Oral Vaccines Price by Type (2021-2032)
  5. 12.2 SAMEA Oral Vaccines Market Size by Application
  6. 12.2.1 SAMEA Oral Vaccines Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Oral Vaccines Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Oral Vaccines Price by Application (2021-2032)
  9. 12.3 SAMEA Oral Vaccines Market Size by Country
  10. 12.3.1 SAMEA Oral Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Oral Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Oral Vaccines Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Oral Vaccines Value Chain Analysis
  2. 13.1.1 Oral Vaccines Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Oral Vaccines Production Mode & Process
  6. 13.2 Oral Vaccines Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Oral Vaccines Distributors
  9. 13.2.3 Oral Vaccines Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst